RedHill Biopharma sells 70% stake in Talicia Holdings to Apotex for $18 million upfront

RDHL•2026-09-30

RedHill Biopharma sold its 70% stake in Talicia Holdings to an Apotex unit for $18 million upfront, with up to $35 million more tied to worldwide net sales milestones.

1. Deal terms

The transaction closed on Aug. 27, 2026. The companies also signed a transition services agreement as part of the handover.

Sources

RedHill Biopharma sells 70% stake in Talicia Holdings to Apotex for $18 million upfront

Sec

RedHill Biopharma sells 70% stake in Talicia Holdings to Apotex for $18 million upfront

1. Deal terms

Related News

AEP backs Bipartisan American Affordability and Jobs Act of 2026, urges Congress to pass bill

Blackstone’s BX Buzz ML Holdcos sell $11.04 million of Bumble common shares

The day ahead—North America, October 1

Sources

RedHill Biopharma sells 70% stake in Talicia Holdings to Apotex for $18 million upfront

ARMOUR Residential REIT Co-CIO Sergey Losyev acquires $10,084 of common shares

E-Home Household Service agrees to private placement of 71.8 million shares for $43.08 million